by Truveta Research | Sep 15, 2026 | Research
Testosterone prescribing increased steadily from 2018 to 2026 across all age groups, with the highest rates among adults aged 45–54. Younger adults experienced the largest relative increase: testosterone prescribing among adults aged 18–34 more than doubled from 2018...
by Truveta staff | Sep 14, 2026 | Research
A study published in Obstetrics & Gynecology used Truveta Data to examine gestational weight gain and pregnancy among individuals classified as overweight or obese who used semaglutide before or during pregnancy Among 1,230 women who used semaglutide before...
by Truveta Research | Sep 9, 2026 | Featured research, Research
Pain medication use was nearly universal in the hospital, with more than 9 in 10 C-sections including acetaminophen, an NSAID, and an opioid. After discharge, NSAIDs and opioids were prescribed after about 6 in 10 C-sections and acetaminophen after about half. The...
by Truveta Research | Sep 1, 2026 | Featured research, Research
The rate of infants not receiving vitamin K injections at birth has increased in recent years, accelerating in 2025 and 2026. In January 2026, 5.2% of births did not have documented receipt of vitamin K, increasing to 8.1% in June 2026, a 57.4% increase. Rates of...
by Truveta Research | Aug 31, 2026 | Research
Authors: Amruta Nori-Sarma, PhD ⊕, Department of Environmental Health, Center for Climate, Health, and the Global Environment, Harvard T.H. Chan School of Public Health, Boston, MA, USA Brianna M. Cartwright, MS ⊕, Truveta, Inc, Bellevue, WA, USA Antonella Zanobetti,...
by Truveta staff | Aug 30, 2026 | Research
Authors: Vidya Venkataraman, PhD ⊕, Truveta, Inc, Bellevue, WA, Jared Kern ⊕, Truveta, Inc, Bellevue, WA, Joud Roufael, MPH ⊕, Truveta, Inc, Bellevue, WA, Puja Rao, MPH ⊕, Truveta, Inc, Bellevue, WA, Joseph Engeda, PhD ⊕, Truveta, Inc, Bellevue, WA, Esther Kim, PhD ⊕,...
